Skip to main content

Mesenchymal Stem Cells 

REPROCELL offers a variety of ready-to-ship products to support research with Mesenchymal Stem Cells (MSCs)—also called Mesenchymal Stromal Cells or Medicinal Signaling Cells. These products include iPSC-derived MSC (iMSC) lines, media, and other culture reagents.

MSCs for clinical use are also available. See GMP MSC Services.

Cat. No. Product name Strain ID Donor Race Donor Sex Donor Age Donor Clinical Status MSC Source Phenol Red-free?
RCRP025 Repro MSC3 RPChMSC003 Asian-Indian Female 20 Healthy Derived from iPSC Strain RPChiPSSK003.2 
(Cat No RCRP011N)
No
RCRP026 Repro MSC4 RPChMSC003 Asian-Indian Female 20 Healthy Derived from iPSC Strain RPChiPSSK003.2
(Cat No RCRP011N)
Yes
RCRP038 Repro MSC10 ReproMSC10 Caucasian Female 22 Healthy Derived from iPSC Strain RPC-LLF-34-F3 Yes
 RCRP049  Repro MSC12 ReproMSC12 Caucasian Male 23 Healthy Derived from iPSC Strain RPC-SKH-44-F19 Yes

RCRP056

ReproMSC16 hTERT SV40

ReproMSC16

Caucasian  Male 23 Healthy

Derived from iMSC Strain ReproMSC12 (Cat No RCRP049)

Yes
RCRP057 StemEdit iMSC B2M/CIITA DKO ReproMSC14 ReproMSC14 Caucasian Female 22 Healthy Derived from iPSC Strain StemEdit hiPSC B2M/CIITA DKO (Cat No RCRP052) Yes
CC-BM-hMSC-1,
CC-BM-hMSC-10
Human Bone Marrow MSCs n/a Varies Varies 18-28 Healthy Human bone marrow  Yes

NOTE: These MSC cell lines are developed for research use only. They are NOT suitable for use in clinical projects.


Brand: StemRNA™ by Stemgent® (REPROCELL®)

REPROCELL’s Ready-to-use MSCs are ideal for differentiation projects. 

Brand: StemRNA™

RCRP025

Ready-to-use, Research-grade Human iPSC-derived Mesenchymal Stem Cells (iMSCs) derived from StemRNA™ iPSCs.

RCRP026

Ready-to-use, Research-grade Human iPSC-derived Mesenchymal Stem Cells (iMSCs) derived from StemRNA™ iPSCs. (Phenol Red-free.)

RCRP038

Repro MSC10 are ready to use Human Mesenchymal Stem Cells (MSCs, also called Mesenchymal Stromal Cells or Medicinal Signaling Cells) generated from one of our StemRNA™ Clinical Pilot lines, RPC-LLF-34-F3 (established from fibroblasts using the StemRNA Reprogramming Technology).

RCRP049

 Repro MSC12 are ready-to-use Human Mesenchymal Stem Cells (MSCs, also called Mesenchymal Stromal Cells or Medicinal Signaling Cells) generated from one of our StemRNA™ Clinical Pilot lines, RPC-SKH-44-F19 (established from fibroblasts using the StemRNA Reprogramming Technology). 

Brand: StemRNA™

RCRP056

Human iPSC-derived MSCs, constitutively immortalized with hTERT and  SV40, generated from one of our StemRNA™ Clinical Pilot lines, RPC-SKH-44-F19 (established from fibroblasts using the StemRNA Reprogramming Technology).  

RCRP057

ReproMSC14 are ready-to-use Human Mesenchymal Stem Cells (MSCs, also called Mesenchymal Stromal Cells or Medicinal Signaling Cells) generated from one of our StemRNA™ Clinical Pilot lines, RPC-LLF-34-F3. The parental iPSC line was established from fibroblasts using the StemRNA Reprogramming Technology that was subsequently engineered with biallelic knockouts of B2M and CIIT, key regulators of HLA Class I and Class II antigen presentation.

Brand: Cellcolabs®

Brand: Cellcolabs™

CC-BM-hMSC-1, CC-BM-hMSC-10

Primary Human Bone Marrow MSCs, Research Grade